| Code | Description | Claims | Beneficiaries | Total Paid |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
10,176 |
3,057 |
$619K |
| 73630 |
|
2,109 |
1,907 |
$75K |
| 64493 |
|
290 |
269 |
$73K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,322 |
1,225 |
$38K |
| 97161 |
|
548 |
490 |
$30K |
| 87641 |
|
1,952 |
1,893 |
$27K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
814 |
750 |
$25K |
| 62323 |
|
158 |
149 |
$24K |
| 87640 |
|
1,890 |
1,832 |
$22K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
834 |
771 |
$16K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
376 |
108 |
$14K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,581 |
1,527 |
$13K |
| 76000 |
|
191 |
187 |
$11K |
| 73610 |
|
231 |
205 |
$9K |
| 73502 |
|
394 |
378 |
$9K |
| 73562 |
|
225 |
209 |
$7K |
| 73030 |
|
184 |
171 |
$6K |
| 85027 |
|
2,414 |
2,016 |
$6K |
| 83735 |
|
2,420 |
2,076 |
$6K |
| 73600 |
|
97 |
90 |
$5K |
| 86900 |
|
927 |
885 |
$4K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,476 |
1,383 |
$2K |
| 99215 |
Prolong outpt/office vis |
25 |
12 |
$2K |
| 86850 |
|
770 |
732 |
$2K |
| 73564 |
|
78 |
77 |
$2K |
| 97116 |
|
70 |
52 |
$1K |
| 20610 |
|
17 |
14 |
$1K |
| 73501 |
|
30 |
27 |
$1K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
505 |
445 |
$1K |
| 72170 |
|
218 |
200 |
$1K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
487 |
466 |
$964.20 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
38 |
12 |
$914.39 |
| 64494 |
|
141 |
133 |
$774.01 |
| 73560 |
|
59 |
52 |
$759.84 |
| 86901 |
|
806 |
767 |
$753.81 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
456 |
372 |
$643.57 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
103 |
91 |
$620.54 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
686 |
664 |
$488.69 |
| 77002 |
|
14 |
14 |
$441.14 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
690 |
684 |
$414.26 |
| 73060 |
|
17 |
13 |
$342.29 |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
285 |
204 |
$317.78 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
131 |
121 |
$311.03 |
| 72110 |
|
26 |
25 |
$282.31 |
| 73565 |
|
67 |
62 |
$270.48 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
21 |
12 |
$158.89 |
| J2704 |
Injection, propofol, 10 mg |
212 |
210 |
$158.89 |
| 99001 |
|
438 |
398 |
$103.06 |
| 85651 |
|
101 |
88 |
$97.65 |
| 84443 |
Thyroid stimulating hormone (TSH) |
28 |
25 |
$86.65 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
13 |
12 |
$61.08 |
| 86140 |
|
30 |
26 |
$31.27 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
41 |
41 |
$27.02 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13 |
12 |
$21.81 |
| 82565 |
|
13 |
12 |
$4.52 |
| Q9966 |
Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
216 |
191 |
$0.00 |
| 80061 |
Lipid panel |
96 |
81 |
$0.00 |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
198 |
193 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
86 |
81 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
59 |
55 |
$0.00 |
| C1776 |
Joint device (implantable) |
14 |
14 |
$0.00 |
| J3490 |
Unclassified drugs |
293 |
195 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
324 |
287 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
526 |
462 |
$0.00 |
| 76377 |
|
16 |
15 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
92 |
89 |
$0.00 |
| Q3014 |
Telehealth originating site facility fee |
60 |
51 |
$0.00 |
| 88300 |
|
15 |
15 |
$0.00 |